0 results available. Select is focused ,type to refine list, press Down to open the menu,
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United State...
The following section summarizes insights on TG Therapeutics Inc's EBITDA Forecast (FINBOX):
We've identified the following companies as similar to TG Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EBITDA Forecast (FINBOX) in the forecast category include:
Forecasted earnings before interest, taxes, depreciation and amortization (EBITDA).
The chart above depicts the distribution of ebitda forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,630 companies were considered in this analysis, and 1,571 had meaningful values. The average ebitda forecast (finbox) of companies in the sector is 156.3 M with a standard deviation of 608.6 M.
TG Therapeutics Inc's EBITDA Forecast (FINBOX) of 198.6 M ranks in the 85.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,637 |
| Included Constituents | 1,571 |
| Min | -324.4 M |
| Max | 5.217 B |
| Median | 3.612 M |
| Mean | 156.3 M |
| Standard Deviation | 608.6 M |
You can find companies with similar ebitda forecast (finbox) using this stock screener.